Antengene Corporation Limited logo

Antengene Corporation Limited

HKEX:6996.HK

Overview | Financials
Company Name Antengene Corporation Limited
Symbol 6996.HK
Currency HKD
Price 0.54
Market Cap 339,760,855
Dividend Yield 0%
52-week-range 0.5 - 2.25
Industry Biotechnology
Sector Healthcare
CEO Dr. Jay Mei M.D., Ph.D.
Website https://www.antengene.com

An error occurred while fetching data.

About Antengene Corporation Limited

Antengene Corporation Limited, a biopharmaceutical company, engages in the development of oncology therapies in China. It offers ATG-016, a second generation XPO1 inhibitor, which is in Phase I/II clinical study in patients with solid tumors; ATG-527 (Verdinexor) that has completed Phase I evaluation for chronic human viral infections; ATG-019, a

Related Stocks

Viva Biotech Holdings logo

Viva Biotech Holdings

1873.HK

0.61 HKD

AK Medical Holdings Limited logo

AK Medical Holdings Limited

1789.HK

4.15 HKD

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. logo

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

1558.HK

8.19 HKD

Peijia Medical Limited logo

Peijia Medical Limited

9996.HK

2.89 HKD

MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd.

2235.HK

3.57 HKD

Ascletis Pharma Inc. logo

Ascletis Pharma Inc.

1672.HK

1.04 HKD

China Shineway Pharmaceutical Group Limited logo

China Shineway Pharmaceutical Group Limited

2877.HK

7.86 HKD

Clover Biopharmaceuticals, Ltd. logo

Clover Biopharmaceuticals, Ltd.

2197.HK

0.218 HKD

Hua Medicine (Shanghai) Ltd. logo

Hua Medicine (Shanghai) Ltd.

2552.HK

1.19 HKD

C-MER Eye Care Holdings Limited logo

C-MER Eye Care Holdings Limited

3309.HK

2.11 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD